This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

Early Diagnosis and Screening: Reaching for the "Gold Standard"

Loading

Early Diagnosis and Screening: Reaching for the "Gold Standard"

25 May 2022
Early Diagnosis and Screening
Early Diagnosis and Screening: Reaching for the

This session has been organised and funded by AstraZeneca UK.  

Collaborations between industry and the NHS are key for achieving optimal, patient-centric cancer care in England1. In lung cancer, the journey starts with adequate screening without which patients may not receive early diagnosis and prompt access to the right treatment for them.

Through a moderated panel discussion, we will showcase how collaborations between the NHS and the pharmaceutical industry can help support access to early diagnosis, improve understanding of the symptoms of lung cancer, and ultimately shift the dial closer to realising the importance of early diagnosis and screening in cancer care.

Delegates will:

-        Hear some of the challenges in lung cancer screening

-        Learn about a best practice case study for a screening collaboration between AstraZeneca and the NHS in lung cancer

-        Hear a panel discussion about the applicability of these findings

-        Be able to ask the panel any questions relating to the topics discussed during the session

 

This is a non-promotional session intended for a healthcare professional audience only.

References:

1.      NHS England. Partnerships and relationships. Cited at www.england.nhs.uk/ourwork/part-rel (last accessed May 2022)

GB-36036 May 2022

Speakers
Jane Derbyshire, Project Lead - Targeted Lung Health Check Programme, RM Partners
Ley Chan, Clinical Research Fellow - Targeted Lung Health Check Programme, RM Partners
Arun Krishna, UK Country Head in Oncology - AstraZeneca